Physician

Ahmed Elsharkawi, M.D.

According to 2025 Medicare claims, Ahmed Elsharkawi, M.D. (NPI: 1861456378) practices nephrology in the Brunswick-St. Simons, GA market, with the plurality of this provider's patient population coming from Glynn, GA. This provider's primary affiliated billing organization is AHMED ELSHARKAWI MD LLC (NPI: 1184856494; TIN: 26-1890109) and primary practice location at 31520-4785.

Elsharkawi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 799 traditional Medicare patients, billed 4,630 HCPCS/CPT codes, and received $409,432 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 19,229 prescription claims across 1,332 beneficiaries totaling $3,779,349 in drug costs, led by Krystexxa (Pegloticase). DME data shows 699 claims. Open Payments data shows 133 records totaling $161,121. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $1,331,153 to $3,779,349. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $29,323 to $45,906.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	767	5,716	$529,461
2016	1,010	8,131	$647,834
2017	1,160	12,882	$770,579
2018	1,045	7,364	$675,174
2019	1,366	9,881	$1,008,224
2020	1,232	7,262	$776,235
2021	1,070	5,618	$625,147
2022	1,026	8,099	$657,819
2023	911	5,544	$500,811
2024	799	4,630	$409,432

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	834	17,196	$1,331,153
2016	989	21,014	$2,168,299
2017	1,081	20,939	$2,001,564
2018	1,148	19,828	$1,817,569
2019	1,331	21,506	$2,212,662
2020	1,373	20,369	$2,218,395
2021	1,387	18,269	$2,350,564
2022	1,322	18,464	$2,502,510
2023	1,317	18,142	$3,202,893
2024	1,332	19,229	$3,779,349

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	147	736	$49,335
2016	132	808	$59,833
2017	90	682	$31,057
2018	155	792	$45,978
2019	179	942	$61,273
2020	83	684	$48,901
2021	31	585	$42,374
2022	23	590	$53,277
2023	12	486	$50,181
2024	51	699	$52,492

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	79	474	$268
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	543	1,392	$86
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	132	313	$60
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	211	1,251	$46
81003	Automated urinalysis test	152	227	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Krystexxa	Pegloticase	14	392	$824,436
Jardiance	Empagliflozin	383	18,780	$366,378
Ozempic	Semaglutide	238	10,206	$333,919
Mounjaro	Tirzepatide	252	8,856	$328,185
Kerendia	Finerenone	278	11,708	$249,712

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	14	57	$26,273
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	12	$12,253
J7507	Tacrolimus, immediate release, oral, 1 mg	N	12	143	$3,831
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	13	195	$2,420
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	12	92	$1,713

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	105	$3,418	CSL Behring
Research Payments	Reported research-related payment or transfer-of-value amount.	28	$157,704	Bayer Healthcare Pharmaceuticals Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmed Elsharkawi, M.D.?

Tedicare shows public-source Medicare data for Ahmed Elsharkawi, M.D. (NPI 1861456378), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed Elsharkawi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ahmed Elsharkawi, M.D.?

Ahmed Elsharkawi, M.D. is linked to AHMED ELSHARKAWI MD LLC (billing NPI 1184856494) in the available physician profile data.

Does Ahmed Elsharkawi, M.D. have Open Payments data?

Ahmed Elsharkawi, M.D. has 133 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.